Skip to main content
Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0189
-0.0011 (-5.50%)
Mar 25, 2025, 10:35 AM EST

Emmaus Life Sciences Revenue

Emmaus Life Sciences had revenue of $5.48M in the quarter ending September 30, 2024, with 9.17% growth. This brings the company's revenue in the last twelve months to $20.43M, down -28.22% year-over-year. In the year 2023, Emmaus Life Sciences had annual revenue of $29.60M with 60.94% growth.

Revenue (ttm)
20.43M
Revenue Growth
-28.22%
P/S Ratio
0.06
Revenue / Employee
385.43K
Employees
55
Market Cap
1.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202329.60M11.21M60.94%
Dec 31, 202218.39M-2.22M-10.77%
Dec 31, 202120.61M-2.56M-11.04%
Dec 31, 202023.17M415.00K1.82%
Dec 31, 201922.75M6.29M38.23%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
SS Innovations International 16.04M
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.60M
Silence Therapeutics 43.26M
American Oncology Network 1.76B
Revenue Rankings

Emmaus Life Sciences News

More News